Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Suppression of EJ cells tumorigenicity

T Tone1, M Kashani-Sabet, T Funato

  • 1Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA 91010.

In Vivo (Athens, Greece)
|November 1, 1993
PubMed
Summary

Hammerhead ribozymes targeting H-ras RNA significantly reduced cancer cell growth and suppressed tumor formation in vivo. This demonstrates the potential of anti-oncogenic ribozymes as a novel class of tumor-suppressing agents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chirality-Induced Phonon-Spin Conversion at an Interface.

Physical review letters·2024
Same author

Dose reconstruction from PET images in carbon ion therapy: a deconvolution approach.

Physics in medicine and biology·2018
Same author

Experimental validation of the FLUKA Monte Carlo code for dose and [Formula: see text]-emitter predictions of radioactive ion beams.

Physics in medicine and biology·2018
Same author

Influence of intra-oral sensory impairment by anaesthesia on food comminution and mixing in dentate subjects.

Journal of oral rehabilitation·2015
Same author

Effectiveness of ultrasound-guided transversus abdominis plane block and rectus sheath block in pain control and recovery after gynecological transumbilical single-incision laparoscopic surgery.

Clinical and experimental obstetrics & gynecology·2015
Same author

MicroRNA-mediated regulation of melanoma.

The British journal of dermatology·2014

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Oncology

Background:

  • Ribozymes are catalytic RNA molecules with nuclease activity.
  • Gene expression manipulation is crucial for cancer therapy.
  • The H-ras oncogene plays a role in various cancers.

Purpose of the Study:

  • To investigate the therapeutic potential of hammerhead ribozymes against H-ras gene expression.
  • To evaluate the efficacy of ribozymes in inhibiting cancer cell growth and tumorigenicity.
  • To establish ribozymes as a novel class of tumor-suppressing agents.

Main Methods:

  • Design and cloning of a hammerhead ribozyme targeting H-ras RNA.
  • Transfection of EJ human bladder carcinoma cells with the ribozyme.
  • In vitro assessment of H-ras gene expression and cell growth.

Related Experiment Videos

  • In vivo evaluation of tumor formation in nude mice.
  • Comparison with a catalytically inactive mutant ribozyme.

    • Main Results:

    • Ribozyme expression significantly reduced H-ras gene expression and EJ cell growth in vitro.
    • In vivo studies showed suppressed tumorigenicity of EJ cells in nude mice.
    • A mutant ribozyme also showed some inhibitory effects, suggesting potential off-target mechanisms.
    • The observed effects on tumorigenicity were stable over extended culture periods.

    Conclusions:

    • Hammerhead ribozymes targeting H-ras are effective in reducing cancer cell proliferation and tumorigenicity.
    • Anti-oncogenic ribozymes represent a promising new strategy for cancer gene therapy.
    • Further research is warranted to fully elucidate the mechanisms and optimize ribozyme-based therapies.